Provided by Tiger Trade Technology Pte. Ltd.

SH PHARMA

11.810
+0.0100.08%
Volume:1.57M
Turnover:18.42M
Market Cap:43.79B
PE:8.53
High:11.830
Open:11.800
Low:11.670
Close:11.800
52wk High:12.821
52wk Low:9.577
Shares:3.71B
HK Float Shares:919.07M
Volume Ratio:0.75
T/O Rate:0.17%
Dividend:0.46
Dividend Rate:3.91%
EPS(LYR):1.384
ROE:7.91%
ROA:2.15%
PB:0.51
PE(LYR):8.53
PS:0.14

Loading ...

Shanghai's Economic Commission Asserts Robust AI Infrastructure: Ample Computing Power for Models, Data for Applications, and Chips for Products

Deep News
·
Yesterday

Shanghai Pharmaceuticals Gets Registration Certificate for Sitagliptin/Metformin Tablets

MT Newswires Live
·
Feb 05

Shanghai Pharmaceutical to Transfer Sino-American Shanghai Squibb Pharmaceutical for Not Less Than 1.02 Billion Yuan

MT Newswires Live
·
Feb 05

Shanghai Pharma Plans Full Divestiture of Stake in Sino-American Shanghai Squibb

Deep News
·
Feb 04

Shanghai Pharmaceuticals Holding to Divest 30% Stake in Sino-American Shanghai Squibb Through Public Listing

Stock News
·
Feb 04

Shanghai Pharma (601607.SH) Receives Manufacturing Approval for Sitagliptin and Metformin Hydrochloride Extended-Release Tablets

Stock News
·
Feb 04

Shanghai Pharmaceuticals (02607) Releases January 2026 Monthly Return on Securities Movements

Bulletin Express
·
Feb 03

Shanghai Pharma (02607): Qiwei Fangji Huangqi Granules Receives Clinical Trial Approval Notice

Stock News
·
Jan 29

Shanghai Pharmaceuticals' Unit Gets Nod for B023 Cell Injection Trial

MT Newswires Live
·
Jan 21

Shanghai Pharmaceuticals' Unit Gets Nod for Marketing of Isavuconazole Sulfate API

MT Newswires Live
·
Jan 14

SH PHARMA (02607) Completes Acquisition of 10% Stake in Finance Company

Stock News
·
Jan 13

Shanghai Pharma (601607.SH): Isavuconazole Sulfate Active Pharmaceutical Ingredient Approved for Market Launch

Stock News
·
Jan 13

Shanghai Pharmaceuticals' Subsidiary Gets Registration Certificate for Pyridostigmine Oral Solution

MT Newswires Live
·
Jan 12

Shanghai Pharmaceuticals (601607.SH): Hydroxychloroquine Sulfate Tablets Obtain Drug Registration Certificate in the Philippines

Stock News
·
Dec 15, 2025

SH PHARMA (02607) to Distribute Interim Dividend of HK$1.3215 per 10 Shares on February 6, 2026

Stock News
·
Dec 09, 2025

Shanghai Pharmaceuticals (601607.SH) Gains Approval for Minoxidil Tincture Production

Stock News
·
Dec 05, 2025

Shanghai Pharma (02607) Releases Indicative Announcement on Extraordinary General Meeting

Bulletin Express
·
Nov 28, 2025

Shanghai Pharmaceuticals (02607) Releases Extraordinary General Meeting Notice

Bulletin Express
·
Nov 18, 2025

Shanghai Pharmaceuticals (02607) Announces Proxy Form for December 2025 EGM

Bulletin Express
·
Nov 18, 2025

SH PHARMA (02607) to Distribute Interim Dividend of RMB1.2 per 10 Shares

Stock News
·
Nov 18, 2025